Form D · Other Health Care
Respiratory Sciences, Inc.
Minneapolis, MN · CIK 0001844231
Offering snapshot reported Feb 5, 2021 · SEC filing
- Reported sold
- $165K Offering amount: $600K
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 21, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 5, 2021 | Initial | $165,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-388604
Source: Form D, filed Feb 5, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Patrick Lichter | Director |
| Daniel Spors | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
706 N 1 St Street Suite 104
Minneapolis, MN, 55401
Minneapolis, MN, 55401